Valeant Pharmaceuticals International says a block of its shares was sold Thursday by Goldman Sachs to repay $100 million US in loans to the drug company's chairman and chief executive, J. Michael Pearson.
Source:CBC | Business News http://ift.tt/1HhcHz2
0 commentaires:
Enregistrer un commentaire